Celularity (CELUW) Preferred Stock Liabilities (2019 - 2021)

Celularity (CELUW) has 3 years of Preferred Stock Liabilities data on file, last reported at $290.9 million in Q2 2021.

• Preferred Stock Liabilities for Q2 2021 came in at $290.9 million, up 57.87% year-over-year; the trailing twelve-month figure through Jun 2021 was $290.9 million (up 57.87% YoY), and the FY2020 annual result was $290.9 million, up 41.17% from the prior year.
• Preferred Stock Liabilities advanced to $290.9 million in Q2 2021 per CELUW's latest filing, from $75.0 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $290.9 million in Q4 2020 and troughed at $75.0 million in Q1 2020.
• A 3-year average of $171.0 million and a median of $184.2 million in 2020 frame the typical range for Preferred Stock Liabilities.
• On a YoY basis, Preferred Stock Liabilities climbed as much as 57.87% in 2021 and fell as far as 0.0% in 2021.
• A 3-year view of Preferred Stock Liabilities shows it stood at $206.0 million in 2019, then soared by 41.17% to $290.9 million in 2020, then changed by 0.0% to $290.9 million in 2021.
• Business Quant data shows CELUW's Preferred Stock Liabilities at $290.9 million in Q2 2021, $75.0 million in Q1 2021, and $290.9 million in Q4 2020.